欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2017, Vol. 22 ›› Issue (7): 795-798.

• 药物治疗学 • 上一篇    下一篇

普瑞巴林联合氦氖激光理疗对带状疱疹后遗神经痛患者疼痛及睡眠质量的影响

阮仁杰,刘茜茜,金华丹,王崇敏   

  1. 浙江省温岭市中医院皮肤科,温岭 317500,浙江
  • 收稿日期:2016-10-20 修回日期:2017-03-31 出版日期:2017-07-26 发布日期:2017-07-19
  • 作者简介:阮仁杰,男,本科,副主任医师,研究方向:皮肤病诊治。 Tel:13858652828 E-mail: WLZYYRRJ@163.com
  • 基金资助:

    浙江省中医药科学研究基金计划(2013ZA038)

Effect of pregabalin combined with Helium-neon laser therapy on pain and sleep of patients with herpes zoster and postherpetic neuralgia

RUAN Renjie, LIU Qianqian, JIN Huadan, WANG Chongmin   

  1. Department of Dermatology,Wenling Hospital of Traditional Chinese Medicine,Wenling 317500,Zhejiang,China
  • Received:2016-10-20 Revised:2017-03-31 Online:2017-07-26 Published:2017-07-19

摘要:

目的: 探讨普瑞巴林联合氦氖激光理疗对带状疱疹后遗神经痛患者疼痛及睡眠质量的影响。方法: 将确诊为带状疱疹后遗神经痛(post herpetic neuralgia,PHN)患者84例分为两组,每组42例。对照组口服普瑞巴林治疗,研究组在对照组治疗基础上行氦氖激光照射治疗。对比两组患者临床症状改善情况、视觉模拟评分法(VAS)评分、匹兹堡睡眠质量指数量表(PSQI)评分。结果: 研究组疗效显著优于对照组,差异有统计学意义(Z=2.660,P<0.05)。治疗1周、2周、1月、2月、3月后,两组VAS评分较治疗前降低,研究组治疗后VAS评分显著低于对照组治疗后,差异有统计学意义(t=3.17、7.27、12.02、19.26、11.79,P<0.05);两组PSQI评分较治疗前降低(P<0.05);研究组治疗后PSQI评分显著低于对照组治疗后,差异有统计学意义(t=2.71、3.74、8.79、9.60、9.91,P<0.05)。结论: 普瑞巴林联合氦氖激光理疗能显著降低PHN患者疼痛值和提升睡眠质量,促进PHN患者临床症状改善。

关键词: 氦氖激光理疗, 普瑞巴林, 带状疱疹后遗神经痛, 视觉模拟评分法, 匹兹堡睡眠质量指数量表

Abstract:

AIM: To investigate the effect of pregabalin combined with Helium-neon laser therapy on pain and sleep of patients with herpes zoster and postherpetic neuralgia.  METHODS: Eighty-four patients, diagnosed as postherpetic neuralgia (PHN) were randomly divided into two groups, with 42 cases in each. Patients in the control group received oral administration of pregabalin while the study group was administered extra Helium-neon laser therapy based on the treatment of the control group. Clinical symptoms, visual analogue scale (VAS) score, Pittsburgh sleep quality index (PSQI) score were compared between the two groups.RESULTS:The study group presented better clinical efficacy than the control group(Z=2.660,P<0.05). After treatment of one week, two weeks, one month, two months and three months, the VAS scores of the two groups were lower than those before treatment (P<0.05), and scores of the study group were significantly lower than those of the control group (t=3.17, 7.27, 12.02, 19.26, 11.79, P<0.05); the PSQI scores of the two groups were lower than those before treatment (P<0.05), and scores of the study group was significantly lower than those of the control group (t=2.71, 3.74, 8.79, 9.60, 9.91, P<0.05).CONCLUSION:Pregabalin combined with Helium-neon laser therapy can significantly improve the clinical patients’ symptoms by relieving pain and improving sleep quality of PHN patients.

Key words: Helium-neon laser therapy, pregabalin, postherpetic neuralgia, VAS, PSQ

中图分类号: